6.
Moodley K, Pather M, Myer L
. Informed consent and participant perceptions of influenza vaccine trials in South Africa. J Med Ethics. 2005; 31(12):727-32.
PMC: 1734072.
DOI: 10.1136/jme.2004.009910.
View
7.
Song K, Chapagain R, Tamrakar D, Shrestha R, Kanodia P, Chaudhary S
. Safety and immunogenicity of the Euvichol-S oral cholera vaccine for prevention of Vibrio cholerae O1 infection in Nepal: an observer-blind, active-controlled, randomised, non-inferiority, phase 3 trial. Lancet Glob Health. 2024; 12(5):e826-e837.
PMC: 11027156.
DOI: 10.1016/S2214-109X(24)00059-7.
View
8.
Saluja T, Giri B, Chaudhary S, Tamrakar D, Kanodia P, Palkar S
. Challenges and opportunities in setting up a phase III vaccine clinical trial in resource limited settings: Experience from Nepal. Hum Vaccin Immunother. 2021; 17(7):2149-2157.
PMC: 8189093.
DOI: 10.1080/21645515.2020.1855955.
View
9.
Yadav S, Todd A, Patel K, Tabriz A, Nguyen O, Turner K
. Public knowledge and information sources for clinical trials among adults in the USA: evidence from a Health Information National Trends Survey in 2020. Clin Med (Lond). 2022; 22(5):416-422.
PMC: 9595001.
DOI: 10.7861/clinmed.2022-0107.
View
10.
Manchikanti L, Hirsch J, Smith H
. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: Part 2: Randomized controlled trials. Pain Physician. 2008; 11(6):717-73.
View
11.
Walsh E, Sheridan A
. Factors affecting patient participation in clinical trials in Ireland: A narrative review. Contemp Clin Trials Commun. 2018; 3:23-31.
PMC: 5935836.
DOI: 10.1016/j.conctc.2016.01.002.
View
12.
Abdelhafiz A, Abd ElHafeez S, Khalil M, Shahrouri M, Alosaim B, Salem R
. Factors Influencing Participation in COVID-19 Clinical Trials: A Multi-National Study. Front Med (Lausanne). 2021; 8:608959.
PMC: 7940528.
DOI: 10.3389/fmed.2021.608959.
View
13.
Choudhury S, Pradhan R, Dubey L, Barman L, Biswas T, Das M
. Knowledge and perception regarding clinical trials among doctors of government medical colleges: A questionnaire-based study. Perspect Clin Res. 2016; 7(2):94-9.
PMC: 4840798.
DOI: 10.4103/2229-3485.179433.
View
14.
Al-Rawashdeh N, Damsees R, Al-Jeraisy M, Al Qasim E, Deeb A
. Knowledge of and attitudes toward clinical trials in Saudi Arabia: a cross-sectional study. BMJ Open. 2019; 9(10):e031305.
PMC: 6830621.
DOI: 10.1136/bmjopen-2019-031305.
View
15.
Chapagain R, Adhikari S, Giri B, Ray P, Shrestha N, Prajapati B
. Factors affecting willingness to participate in vaccine clinical trials in an underdeveloped country: perspective from Nepal. Hum Vaccin Immunother. 2022; 18(5):2051413.
PMC: 9225427.
DOI: 10.1080/21645515.2022.2051413.
View
16.
DasMahapatra P, Raja P, Gilbert J, Wicks P
. Clinical trials from the patient perspective: survey in an online patient community. BMC Health Serv Res. 2017; 17(1):166.
PMC: 5327530.
DOI: 10.1186/s12913-017-2090-x.
View
17.
Al-Lawati H, Al-Baimani K, Al-Zadjali M, Al-Obaidani N, Al-Kiyumi Z, Al-Khabori M
. Knowledge and Attitudes Towards Clinical Trial Participation in Oman: A cross-sectional study. Sultan Qaboos Univ Med J. 2018; 18(1):e54-e60.
PMC: 5892814.
DOI: 10.18295/squmj.2018.18.01.009.
View
18.
Detoc M, Bruel S, Frappe P, Tardy B, Botelho-Nevers E, Gagneux-Brunon A
. Intention to participate in a COVID-19 vaccine clinical trial and to get vaccinated against COVID-19 in France during the pandemic. Vaccine. 2020; 38(45):7002-7006.
PMC: 7498238.
DOI: 10.1016/j.vaccine.2020.09.041.
View
19.
Fares S, Elmnyer M, Mohamed S, Elsayed R
. COVID-19 Vaccination Perception and Attitude among Healthcare Workers in Egypt. J Prim Care Community Health. 2021; 12:21501327211013303.
PMC: 8111272.
DOI: 10.1177/21501327211013303.
View
20.
Chu S, Kim E, Jeong S, Park G
. Factors associated with willingness to participate in clinical trials: a nationwide survey study. BMC Public Health. 2015; 15:10.
PMC: 4306240.
DOI: 10.1186/s12889-014-1339-0.
View